• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯 B 群链球菌临床分离株的分子分型和抗菌药物耐药性。

Molecular typing and antimicrobial resistance of group B Streptococcus clinical isolates in Saudi Arabia.

机构信息

Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia; Department of Microbiology and Immunology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.

出版信息

J Glob Antimicrob Resist. 2023 Dec;35:244-251. doi: 10.1016/j.jgar.2023.10.007. Epub 2023 Oct 14.

DOI:10.1016/j.jgar.2023.10.007
PMID:37844802
Abstract

OBJECTIVES

Group B Streptococcus (GBS) has emerged as an important cause of severe infections in adults. However, limited data are available regarding the epidemiology of GBS in Saudi Arabia.

METHODS

Isolates were collected over a period of eight months from colonized (n = 104) and infected adults (n = 95). Serotypes and virulence determinants were detected by polymerase chain reactions (PCRs). Genetic relatedness was assessed using Multiple Locus Variable Number Tandem Repeat Analysis (MLVA). Antimicrobial susceptibilities were determined by disk diffusion.

RESULTS

Serotypes III and V (25% each) were the most prevalent, followed by serotypes II (16.18%), Ia (13.24%), VI (9.31%), and Ib (8.82%), while five isolates remained non-typeable (2.45%). Hypervirulent serotype III/CC17 clone (n = 21) accounted for 41.18% of the serotype III isolates. Most isolates (53.92%) harboured pilus island (PI) 1 and 2a types, while PI-2b was predominantly detected in the hypervirulent clone. Isolates were variably resistant to tetracycline (76.47%), erythromycin (36.76%), clindamycin (25.49%), and levofloxacin (6.37%), but remained susceptible to penicillin. Macrolide resistant isolates exhibited constitutive (55.42%) and inducible macrolide-lincosamide-streptogramin B resistance phenotypes (33.74%), while a few had L (9.64%) or M (1.2%) phenotypes. MLVA patterns of dominant serotypes III and V revealed 40 different types divided into 12 clusters and 28 singletons. Interestingly, macrolide resistance was significantly associated with two major MLVA types.

CONCLUSIONS

GBS isolates belonged predominantly to serotypes III and V, but there were no clear associations between serotypes and patient groups. The studied isolates exhibited high levels of resistance to erythromycin and clindamycin that need further surveillance.

摘要

目的

B 群链球菌(GBS)已成为成人严重感染的重要病因。然而,沙特阿拉伯有关 GBS 流行病学的数据有限。

方法

在 8 个月的时间里,从定植(n=104)和感染的成人(n=95)中采集分离株。通过聚合酶链反应(PCR)检测血清型和毒力决定因素。使用多位点可变数目串联重复分析(MLVA)评估遗传相关性。通过圆盘扩散法测定抗菌药物敏感性。

结果

血清型 III 和 V(各占 25%)最为常见,其次是血清型 II(16.18%)、Ia(13.24%)、VI(9.31%)和 Ib(8.82%),而 5 个分离株仍无法定型(2.45%)。高毒力血清型 III/CC17 克隆(n=21)占血清型 III 分离株的 41.18%。大多数分离株(53.92%)携带菌毛岛(PI)1 和 2a 型,而 PI-2b 主要存在于高毒力克隆中。分离株对四环素(76.47%)、红霉素(36.76%)、克林霉素(25.49%)和左氧氟沙星(6.37%)的耐药性不同,但仍对青霉素敏感。大环内酯类耐药株表现出固有(55.42%)和诱导型大环内酯类-林可酰胺类-链阳性菌素 B 耐药表型(33.74%),而少数有 L(9.64%)或 M(1.2%)表型。主要血清型 III 和 V 的 MLVA 模式显示 40 种不同类型,分为 12 个簇和 28 个单倍型。有趣的是,大环内酯类耐药与两种主要 MLVA 类型显著相关。

结论

GBS 分离株主要属于血清型 III 和 V,但血清型与患者群体之间没有明确关联。所研究的分离株对红霉素和克林霉素的耐药水平较高,需要进一步监测。

相似文献

1
Molecular typing and antimicrobial resistance of group B Streptococcus clinical isolates in Saudi Arabia.沙特阿拉伯 B 群链球菌临床分离株的分子分型和抗菌药物耐药性。
J Glob Antimicrob Resist. 2023 Dec;35:244-251. doi: 10.1016/j.jgar.2023.10.007. Epub 2023 Oct 14.
2
Commensal Streptococcus agalactiae isolated from patients seen at University Hospital of Londrina, Paraná, Brazil: capsular types, genotyping, antimicrobial susceptibility and virulence determinants.巴西帕拉那州隆德里纳大学医院就诊患者分离的共生性无乳链球菌:荚膜型、基因分型、抗菌药物敏感性和毒力决定因素。
BMC Microbiol. 2013 Dec 21;13:297. doi: 10.1186/1471-2180-13-297.
3
Genomic insights into the diversity, virulence, and antimicrobial resistance of group B clinical isolates from Saudi Arabia.基因组视角下的沙特阿拉伯 B 群临床分离株的多样性、毒力和抗微生物药物耐药性。
Front Cell Infect Microbiol. 2024 Apr 22;14:1377993. doi: 10.3389/fcimb.2024.1377993. eCollection 2024.
4
[Serotypes and antimicrobial susceptibility of Streptococcus agalactiae].[无乳链球菌的血清型及抗菌药敏性]
Rev Med Chil. 2004 May;132(5):549-55. doi: 10.4067/s0034-98872004000500003.
5
Prevalence, population structure, distribution of serotypes, pilus islands and resistance genes among erythromycin-resistant colonizing and invasive Streptococcus agalactiae isolates recovered from pregnant and non-pregnant women in Isfahan, Iran.伊朗伊斯法罕市孕妇和非孕妇定植和侵袭性无乳链球菌分离株中红霉素耐药株的流行率、人群结构、血清型分布、菌毛岛和耐药基因。
BMC Microbiol. 2021 May 4;21(1):139. doi: 10.1186/s12866-021-02186-2.
6
Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility.巴西无乳链球菌:血清型分布、毒力决定因素和抗菌药物敏感性。
BMC Infect Dis. 2014 Jun 12;14:323. doi: 10.1186/1471-2334-14-323.
7
Phenotypes, genotypes, serotypes and molecular epidemiology of erythromycin-resistant Streptococcus agalactiae in Italy.意大利耐红霉素无乳链球菌的表型、基因型、血清型和分子流行病学。
Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1741-7. doi: 10.1007/s10096-011-1495-4. Epub 2011 Nov 26.
8
Macrolide and lincosamide resistance of Streptococcus agalactiae in pregnant women in Poland.波兰孕妇中无乳链球菌的大环内酯类和林可酰胺类耐药性。
Sci Rep. 2024 Feb 16;14(1):3877. doi: 10.1038/s41598-024-54521-y.
9
Microbiological and clinical characteristics of Group B Streptococcus isolates causing materno-neonatal infections: high prevalence of CC17/PI-1 and PI-2b sublineage in neonatal infections.B 群链球菌致母婴感染的微生物学和临床特征:新生儿感染中 CC17/PI-1 和 PI-2b 亚谱系流行率高。
J Med Microbiol. 2018 Nov;67(11):1551-1559. doi: 10.1099/jmm.0.000849. Epub 2018 Sep 28.
10
Molecular epidemiology and distribution of serotypes, genotypes, and antibiotic resistance genes of Streptococcus agalactiae clinical isolates from Guelma, Algeria and Marseille, France.来自阿尔及利亚盖勒马和法国马赛的无乳链球菌临床分离株的分子流行病学、血清型、基因型及抗生素耐药基因分布
Eur J Clin Microbiol Infect Dis. 2015 Dec;34(12):2339-48. doi: 10.1007/s10096-015-2487-6. Epub 2015 Sep 28.

引用本文的文献

1
Clindamycin-resistant among Staphylococcus aureus: Investigation into phenotypic and genotypic profiles.金黄色葡萄球菌对克林霉素的耐药性:表型和基因型特征研究。
PLoS One. 2025 Aug 18;20(8):e0329467. doi: 10.1371/journal.pone.0329467. eCollection 2025.
2
Genetic diversity of Streptococcus agalactiae from dairy cattle with mastitis in Argentina.阿根廷患乳腺炎奶牛中无乳链球菌的遗传多样性
BMC Vet Res. 2025 May 13;21(1):338. doi: 10.1186/s12917-025-04584-4.
3
Global patterns of antibiotic resistance in group B : a systematic review and meta-analysis.
B组抗生素耐药性的全球模式:一项系统评价和荟萃分析。
Front Microbiol. 2025 Apr 16;16:1541524. doi: 10.3389/fmicb.2025.1541524. eCollection 2025.
4
Group B streptococcal infections in pregnancy and early life.孕期及生命早期的B族链球菌感染
Clin Microbiol Rev. 2025 Mar 13;38(1):e0015422. doi: 10.1128/cmr.00154-22. Epub 2024 Nov 25.
5
Molecular Basis of Antimicrobial Resistance in Group B Clinical Isolates from Saudi Arabia.沙特阿拉伯B组临床分离株中抗菌药物耐药性的分子基础
Infect Drug Resist. 2024 Aug 27;17:3715-3722. doi: 10.2147/IDR.S466726. eCollection 2024.
6
Genomic insights into the diversity, virulence, and antimicrobial resistance of group B clinical isolates from Saudi Arabia.基因组视角下的沙特阿拉伯 B 群临床分离株的多样性、毒力和抗微生物药物耐药性。
Front Cell Infect Microbiol. 2024 Apr 22;14:1377993. doi: 10.3389/fcimb.2024.1377993. eCollection 2024.
7
Recent development and fighting strategies for lincosamide antibiotic resistance.林可酰胺类抗生素耐药性的最新研究进展与应对策略。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0016123. doi: 10.1128/cmr.00161-23. Epub 2024 Apr 18.
8
Re-framing the importance of Group B as a gut-resident pathobiont.重新构建 B 群作为肠道常驻条件致病菌的重要性。
Infect Immun. 2024 Sep 10;92(9):e0047823. doi: 10.1128/iai.00478-23. Epub 2024 Mar 4.
9
Capsular gene distribution and RAPD typing of Streptococcus agalactiae isolated from pregnant women.从孕妇中分离出的无乳链球菌的荚膜基因分布及随机扩增多态性DNA分型
AMB Express. 2024 Jan 28;14(1):13. doi: 10.1186/s13568-024-01671-x.